166 related articles for article (PubMed ID: 11709728)
1. Identification of a C-terminal tripeptide motif involved in the control of rapid proteasomal degradation of c-Fos proto-oncoprotein during the G(0)-to-S phase transition.
Acquaviva C; Brockly F; Ferrara P; Bossis G; Salvat C; Jariel-Encontre I; Piechaczyk M
Oncogene; 2001 Nov; 20(51):7563-72. PubMed ID: 11709728
[TBL] [Abstract][Full Text] [Related]
2. The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression.
Ferrara P; Andermarcher E; Bossis G; Acquaviva C; Brockly F; Jariel-Encontre I; Piechaczyk M
Oncogene; 2003 Mar; 22(10):1461-74. PubMed ID: 12629509
[TBL] [Abstract][Full Text] [Related]
3. Differential directing of c-Fos and c-Jun proteins to the proteasome in serum-stimulated mouse embryo fibroblasts.
Salvat C; Jariel-Encontre I; Acquaviva C; Omura S; Piechaczyk M
Oncogene; 1998 Jul; 17(3):327-37. PubMed ID: 9690514
[TBL] [Abstract][Full Text] [Related]
4. c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivo.
Bossis G; Ferrara P; Acquaviva C; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2003 Oct; 23(20):7425-36. PubMed ID: 14517309
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer.
Basbous J; Chalbos D; Hipskind R; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2007 Jun; 27(11):3936-50. PubMed ID: 17371847
[TBL] [Abstract][Full Text] [Related]
6. Cellular and viral Fos proteins are degraded by different proteolytic systems.
Acquaviva C; Salvat C; Brockly F; Bossis G; Ferrara P; Piechaczyk M; Jariel-Encontre I
Oncogene; 2001 Feb; 20(8):942-50. PubMed ID: 11314029
[TBL] [Abstract][Full Text] [Related]
7. Multiple degradation pathways for Fos family proteins.
Acquaviva C; Bossis G; Ferrara P; Brockly F; Jariel-Encontre I; Piechaczyk M
Ann N Y Acad Sci; 2002 Nov; 973():426-34. PubMed ID: 12485905
[TBL] [Abstract][Full Text] [Related]
8. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids.
Wallace AD; Cidlowski JA
J Biol Chem; 2001 Nov; 276(46):42714-21. PubMed ID: 11555652
[TBL] [Abstract][Full Text] [Related]
9. Evasion from proteasomal degradation by mutated Fos proteins expressed from FBJ-MSV and FBR-MSV osteosarcomatogenic retroviruses.
Acquaviva C; Bossis G; Ferrara P; Brockly F; Jariel-Encontre I; Piechaczyk M
Biochem Pharmacol; 2002 Sep; 64(5-6):957-61. PubMed ID: 12213592
[TBL] [Abstract][Full Text] [Related]
10. NPDC-1, a novel regulator of neuronal proliferation, is degraded by the ubiquitin/proteasome system through a PEST degradation motif.
Spencer ML; Theodosiou M; Noonan DJ
J Biol Chem; 2004 Aug; 279(35):37069-78. PubMed ID: 15229225
[TBL] [Abstract][Full Text] [Related]
11. Degradation of cellular and viral Fos proteins.
Acquaviva C; Ferrara P; Bossis G; Brockly F; Salvat C; Jariel-Encontre I; Piechaczyk M
Biochimie; 2001; 83(3-4):357-62. PubMed ID: 11295497
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. Sequence homology to coding region instability determinants in other mRNAs.
Tierney MJ; Medcalf RL
J Biol Chem; 2001 Apr; 276(17):13675-84. PubMed ID: 11278713
[TBL] [Abstract][Full Text] [Related]
13. c-Fos phosphorylation induced by H2O2 prevents proteasomal degradation of c-Fos in cardiomyocytes.
Coronella-Wood J; Terrand J; Sun H; Chen QM
J Biol Chem; 2004 Aug; 279(32):33567-74. PubMed ID: 15136564
[TBL] [Abstract][Full Text] [Related]
14. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
Kutz SM; Providence KM; Higgins PJ
Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
[TBL] [Abstract][Full Text] [Related]
15. Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway.
Yaguchi H; Ohkura N; Takahashi M; Nagamura Y; Kitabayashi I; Tsukada T
Mol Cell Biol; 2004 Aug; 24(15):6569-80. PubMed ID: 15254225
[TBL] [Abstract][Full Text] [Related]
16. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.
Gregory MA; Hann SR
Mol Cell Biol; 2000 Apr; 20(7):2423-35. PubMed ID: 10713166
[TBL] [Abstract][Full Text] [Related]
17. NoBP, a nuclear fibroblast growth factor 3 binding protein, is cell cycle regulated and promotes cell growth.
Reimers K; Antoine M; Zapatka M; Blecken V; Dickson C; Kiefer P
Mol Cell Biol; 2001 Aug; 21(15):4996-5007. PubMed ID: 11438656
[TBL] [Abstract][Full Text] [Related]
18. Fos family protein degradation by the proteasome.
Gomard T; Jariel-Encontre I; Basbous J; Bossis G; Moquet-Torcy G; Piechaczyk M
Biochem Soc Trans; 2008 Oct; 36(Pt 5):858-63. PubMed ID: 18793151
[TBL] [Abstract][Full Text] [Related]
19. The COOH-terminal domain of wild-type Cot regulates its stability and kinase specific activity.
Gándara ML; López P; Hernando R; Castaño JG; Alemany S
Mol Cell Biol; 2003 Oct; 23(20):7377-90. PubMed ID: 14517305
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase.
Chen RH; Abate C; Blenis J
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):10952-6. PubMed ID: 8248197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]